Univest
Univest
  • Markets

ANLON HEALTHCARE LIMITED Hits Upper Circuit on BSE, 21 September 2026

  • September 21, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
ANLON HEALTHCARE LIMITED Hits Upper Circuit on BSE, 21 September 2026

On 21 September 2026, ANLON HEALTHCARE LIMITED (AHCL) hit the upper circuit on BSE at Rs 27.52, a 19.97% positive move from the previous close of Rs 22.94. The company’s market cap stood at Rs 1219.3 crore. The upper circuit price for the session was Rs 27.52.

The move was driven by buying interest against the exchange-defined price band. At the time of writing the stock was locked at its upper circuit level, which makes the session worth noting for short-term market participants.

Table of Contents

Toggle
  • Key Takeaways
  • Key Market Data
  • Price Action and Trading Activity
  • Why ANLON HEALTHCARE LIMITED Hit Upper Circuit
  • What the Upper Circuit Means
  • ANLON HEALTHCARE LIMITED Fundamentals and Valuation
  • Peer and Sector Context
  • Technical and Ownership Snapshot
  • What Readers Should Know
  • Frequently Asked Questions
    • Why did ANLON HEALTHCARE LIMITED hit upper circuit on 21 September 2026?
    • What was AHCL share price on 21 September 2026?
    • What was the upper circuit price for AHCL?
    • What is ANLON HEALTHCARE LIMITED’s market cap and PE ratio?
    • Which exchange and data source were used?
    • Does hitting an upper circuit mean ANLON HEALTHCARE LIMITED is a buy or a sell?
    • Can you buy or sell ANLON HEALTHCARE LIMITED shares when the stock is at the upper circuit?
    • What happens the next trading session after an upper circuit?
    • What is the upper circuit limit set at for Indian stocks?
  • Footer Disclosure

Key Takeaways

  • ANLON HEALTHCARE LIMITED (AHCL) hit the upper circuit on BSE at Rs 27.52 on 21 September 2026.
  • The session move was +19.97% against a previous close of Rs 22.94.
  • Market capitalisation stood at Rs 1219.3 crore with a PE ratio of 42.76.
  • No official company announcement or verified catalyst was confirmed at the time of writing.
  • A price band is an exchange trading rule, not a view on the company or a recommendation.

Key Market Data

Metric Value
Stock ANLON HEALTHCARE LIMITED
Current Price / LTP Rs 27.52
Day Move 19.97%
Previous Close Rs 22.94
Day Open Rs 23.03
Day High Rs 27.52
Day Low Rs 23.03
Upper Circuit Price Rs 27.52
Upper Circuit Limit Rs 27.52
Market Cap Rs 1219.3 crore
Selected Exchange BSE
PE Ratio 42.76

All figures above are as of 21 September 2026, sourced from Univest market data for the BSE listing. Only fields present in the source for this session are shown.

Price Action and Trading Activity

ANLON HEALTHCARE LIMITED opened at Rs 23.03 on BSE, compared with a previous close of Rs 22.94. During the session, the stock traded between Rs 23.03 and Rs 27.52 before touching the upper circuit price of Rs 27.52.

The absolute day change was Rs 4.58, while the percentage move was 19.97%. The event figures are kept to a single exchange so the numbers stay comparable.

The selected exchange matters because price bands, day range, and previous-close values can differ across exchanges. This article uses BSE consistently for the event table and narrative. The stated upper circuit limit for the session was Rs 27.52, which is the level the price reached.

Why ANLON HEALTHCARE LIMITED Hit Upper Circuit

ANLON HEALTHCARE LIMITED hit the upper circuit after buying interest pushed the stock to its exchange-defined price band. No official company announcement or verified external catalyst was confirmed at the time of writing, so the move should be read primarily through price action and market sentiment.

Because no verified catalyst was available, this article does not attribute the move to earnings, corporate action, sector news, or market rumours. If a confirmed announcement becomes available later, it should be added as a separate update.

Within the session the stock reached the upper circuit level of Rs 27.52.

What the Upper Circuit Means

An upper circuit is the maximum price level a stock is allowed to reach during a trading session under the applicable exchange price band. For ANLON HEALTHCARE LIMITED, the captured upper circuit price was Rs 27.52 on 21 September 2026.

The circuit mechanism is meant to slow extreme price movement and keep trading orderly. It is a market-structure fact, not a return forecast. In this article, the upper circuit explains what happened in the session and where the price band was reached.

ANLON HEALTHCARE LIMITED Fundamentals and Valuation

Available market data gives a fuller picture than price action alone. For ANLON HEALTHCARE LIMITED, PE ratio was 42.76, PB ratio was 4.18, book value was Rs 5.49, EPS was 0.54, ROE was 18.73%, ROCE was 21.98%, dividend yield was 0% and debt-to-assets ratio was 0.19, on a market cap of Rs 1219.3 crore. These are available financial indicators and should not be read as a buy, sell, or hold view.

A PB ratio above 1 means the market price was above the reported book value per share. That premium can reflect growth expectations, asset quality, or simply thin trading in a smaller counter.

For investors tracking upper circuit moves, these metrics help separate the price event from the broader financial profile. A sharp one-day move can attract attention, but valuation and return ratios still need to be reviewed separately.

Peer and Sector Context

ANLON HEALTHCARE LIMITED belongs to the Pharmaceuticals & Drugs industry within the Healthcare sector. The peer table below uses available companies from the same sector or industry to give broader valuation context.

Peer Company Market Cap PE PB ROE
Advanced Enzyme Technologies Ltd. Rs 3226.59 crore 19.45 1.94 12.04%
Hikal Ltd. Rs 2787.83 crore – 2.34 16.04%
Dishman Carbogen Amcis Ltd. Rs 2672.37 crore 165.37 0.4 -2.89%
Sakar Healthcare Ltd. Rs 2625.04 crore 72.72 7.84 11.88%
Indoco Remedies Ltd. Rs 2301.59 crore 408.81 2.31 18.5%

A dash in the PE column means no PE ratio was carried for that company in the source data, which happens when reported earnings are negative or have not been refreshed. Those companies are left out of the average below rather than counted as zero.

ANLON HEALTHCARE LIMITED’s PE ratio was 42.76, compared with an available peer/sector PE average of 133.27, calculated from the 4 peer companies that had a PE on record. This comparison is a valuation reference point, not a recommendation.

Want to know more? Log in to Univest for more stock insights.

Technical and Ownership Snapshot

The technical snapshot adds context: RSI was 82.82, the 50-day moving average was 15.74 and the 200-day moving average was 14.14.

Shareholding details were not available in the latest market dataset, so no conclusion is drawn about promoter, institutional, or public-shareholder activity.

What Readers Should Know

The main confirmed fact is that ANLON HEALTHCARE LIMITED hit the upper circuit on BSE at Rs 27.52 on 21 September 2026, with a 19.97% day move.

The practical limitation after an upper-circuit session is execution. Buyers queue at the band and sellers step back, so the quoted price is not necessarily a price you can transact at. The other limitation is that no official catalyst was confirmed at the time of writing.

Readers should treat upper circuit events as market updates, not standalone investment conclusions. The price band shows strong near-term interest, but follow-up analysis should consider business fundamentals, valuation, liquidity, risk, and confirmed company disclosures.

Frequently Asked Questions

Why did ANLON HEALTHCARE LIMITED hit upper circuit on 21 September 2026?

The stock reached its upper price band after buying interest during the session. No official company announcement or verified external catalyst was confirmed at the time of writing.

What was AHCL share price on 21 September 2026?

The last traded price used in this article was Rs 27.52 on BSE. That price matched the upper circuit price captured for the event.

What was the upper circuit price for AHCL?

The upper circuit price was Rs 27.52. The stated exchange upper circuit limit was Rs 27.52. The event numbers in this article are aligned to BSE.

What is ANLON HEALTHCARE LIMITED’s market cap and PE ratio?

ANLON HEALTHCARE LIMITED’s market cap was Rs 1219.3 crore. PE ratio was 42.76.

Which exchange and data source were used?

The selected exchange was BSE. The article uses Univest market data available at the time of generation, captured on 21 September 2026.

Does hitting an upper circuit mean ANLON HEALTHCARE LIMITED is a buy or a sell?

No. A circuit is an exchange price-band rule that caps how far a stock can move in a single session. It carries no view on valuation or business quality and is not a recommendation. Any decision should rest on fundamentals, valuation, liquidity and your own risk tolerance.

Can you buy or sell ANLON HEALTHCARE LIMITED shares when the stock is at the upper circuit?

It is usually difficult. At the upper circuit, buy orders queue up while sellers step back, so there may be no counterparty at the quoted price. Orders can stay unfilled until the band opens up or sellers return.

What happens the next trading session after an upper circuit?

There is no fixed outcome. The band resets each session, so the stock can open freely, hit the same band again, or reverse. The exchange can also revise the applicable band width. The useful signals to watch are whether the company files any disclosure explaining the move.

What is the upper circuit limit set at for Indian stocks?

Exchange price bands are commonly set at 2%, 5%, 10% or 20% depending on the security, and the applicable band can be revised by the exchange. For ANLON HEALTHCARE LIMITED the stated limit was Rs 27.52. For this session, ANLON HEALTHCARE LIMITED moved 19.97%.

Footer Disclosure

This article is for informational purposes only and does not constitute investment advice. Research services are provided by Uniapps Investment Adviser Pvt. Ltd., a wholly owned subsidiary of Univest, SEBI RIA registration number INA000017639.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply